Spirobarbital

A barbiturate derivative used as a sedative and hypnotic

Spirobarbital
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Spirobarbital is a barbiturate derivative that has been used primarily as a sedative and hypnotic agent. It is known for its central nervous system depressant effects, which make it effective in inducing sleep and reducing anxiety.

Chemical Structure

Chemical structure of Spirobarbital

Spirobarbital is characterized by its unique chemical structure, which includes a spiro linkage. This structure is responsible for its pharmacological properties and its classification as a barbiturate.

Pharmacology

Spirobarbital acts on the gamma-aminobutyric acid (GABA) receptor, enhancing the inhibitory effects of GABA in the central nervous system. This action results in sedation, hypnosis, and anxiolysis. Like other barbiturates, it can cause respiratory depression and coma in overdose situations.

Medical Uses

Spirobarbital has been used in the treatment of insomnia and anxiety disorders. It is effective in inducing sleep and calming patients, but its use is limited due to the potential for dependence and tolerance.

Side Effects

Common side effects of spirobarbital include drowsiness, dizziness, and headache. Long-term use can lead to physical dependence and withdrawal symptoms upon discontinuation.

History

Spirobarbital was developed in the early 20th century as part of the search for effective sedative-hypnotic agents. It was used clinically for several decades before being largely replaced by benzodiazepines and other newer agents with improved safety profiles.

Related pages

• Barbiturate
• Sedative
• Hypnotic
• GABA receptor